Cargando…
The crucial role of multiomic approach in cancer research and clinically relevant outcomes
Cancer with heavily economic and social burden is the hot point in the field of medical research. Some remarkable achievements have been made; however, the exact mechanisms of tumor initiation and development remain unclear. Cancer is a complex, whole-body disease that involves multiple abnormalitie...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833337/ https://www.ncbi.nlm.nih.gov/pubmed/29515689 http://dx.doi.org/10.1007/s13167-018-0128-8 |
_version_ | 1783303464101609472 |
---|---|
author | Lu, Miaolong Zhan, Xianquan |
author_facet | Lu, Miaolong Zhan, Xianquan |
author_sort | Lu, Miaolong |
collection | PubMed |
description | Cancer with heavily economic and social burden is the hot point in the field of medical research. Some remarkable achievements have been made; however, the exact mechanisms of tumor initiation and development remain unclear. Cancer is a complex, whole-body disease that involves multiple abnormalities in the levels of DNA, RNA, protein, metabolite and medical imaging. Biological omics including genomics, transcriptomics, proteomics, metabolomics and radiomics aims to systematically understand carcinogenesis in different biological levels, which is driving the shift of cancer research paradigm from single parameter model to multi-parameter systematical model. The rapid development of various omics technologies is driving one to conveniently get multi-omics data, which accelerates predictive, preventive and personalized medicine (PPPM) practice allowing prediction of response with substantially increased accuracy, stratification of particular patients and eventual personalization of medicine. This review article describes the methodology, advances, and clinically relevant outcomes of different “omics” technologies in cancer research, and especially emphasizes the importance and scientific merit of integrating multi-omics in cancer research and clinically relevant outcomes. |
format | Online Article Text |
id | pubmed-5833337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-58333372018-03-07 The crucial role of multiomic approach in cancer research and clinically relevant outcomes Lu, Miaolong Zhan, Xianquan EPMA J Review Cancer with heavily economic and social burden is the hot point in the field of medical research. Some remarkable achievements have been made; however, the exact mechanisms of tumor initiation and development remain unclear. Cancer is a complex, whole-body disease that involves multiple abnormalities in the levels of DNA, RNA, protein, metabolite and medical imaging. Biological omics including genomics, transcriptomics, proteomics, metabolomics and radiomics aims to systematically understand carcinogenesis in different biological levels, which is driving the shift of cancer research paradigm from single parameter model to multi-parameter systematical model. The rapid development of various omics technologies is driving one to conveniently get multi-omics data, which accelerates predictive, preventive and personalized medicine (PPPM) practice allowing prediction of response with substantially increased accuracy, stratification of particular patients and eventual personalization of medicine. This review article describes the methodology, advances, and clinically relevant outcomes of different “omics” technologies in cancer research, and especially emphasizes the importance and scientific merit of integrating multi-omics in cancer research and clinically relevant outcomes. Springer International Publishing 2018-02-21 /pmc/articles/PMC5833337/ /pubmed/29515689 http://dx.doi.org/10.1007/s13167-018-0128-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Lu, Miaolong Zhan, Xianquan The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title | The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title_full | The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title_fullStr | The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title_full_unstemmed | The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title_short | The crucial role of multiomic approach in cancer research and clinically relevant outcomes |
title_sort | crucial role of multiomic approach in cancer research and clinically relevant outcomes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833337/ https://www.ncbi.nlm.nih.gov/pubmed/29515689 http://dx.doi.org/10.1007/s13167-018-0128-8 |
work_keys_str_mv | AT lumiaolong thecrucialroleofmultiomicapproachincancerresearchandclinicallyrelevantoutcomes AT zhanxianquan thecrucialroleofmultiomicapproachincancerresearchandclinicallyrelevantoutcomes AT lumiaolong crucialroleofmultiomicapproachincancerresearchandclinicallyrelevantoutcomes AT zhanxianquan crucialroleofmultiomicapproachincancerresearchandclinicallyrelevantoutcomes |